ESTRO37_ProgrammeBook

SYMPOSIUM How to minimise toxicity in pelvic malignancies in the era of precision radiotherapy

SATURDAY 21 APRIL 2018

16:15 - 17:30  | ROOM 116 Chair: S. Magrini (Italy) Co-Chair: T. Janssen (The Netherlands)

16:15 > Hematologic toxicity during RT for pelvic malignancies: how to reduce it? P. Franco (Italy), F. Arcadipane, S. Martini, G.C. Iorio, U. Ricardi 16:33 > High precision prostate radiotherapy: a bigger bang for your buck Speaker: H. De Boer (The Netherlands) 16:51 > Preserving bladder function with brachytherapy for muscle-invasive bladder carcinoma Speaker: B. Pieters (The Netherlands)

SP-0145

SP-0146

SP-0147

17:09 > Determinants of toxicity in pelvic radiotherapy Speaker: R. De Crevoisier (France)

SP-0148

PROFFERED PAPERS

RB 2: Biomarkers 16:15 - 17:30  | ROOM 120-121 Chair: C. West (United Kingdom) Chair: M. De Jong (The Netherlands)

16:15 > Intratumoral heterogeneity and hypoxia gene expression signatures in cervix cancer J. Lukovic (Canada), K. Han, M. Pintilie, N. Chaudary, R. Hill, A. Fyles, M. Milosevic 16:25 > Assessing the immune contexture of anal squamous cell carcinoma D. Martin (Germany), P. Balermpas, R. Winkelmann, U. Wieland, M. Rave-Fränk, C. Helmke, M. Raab, J. Kitz, Y. Matthess, K. Strebhardt, C. Rödel, F. Rödel, E. Fokas 16:35 > Potential predictive biomarkers of chemoradiation response in rectal cancer: a metabolomic study C. Rosa (Italy), F. Perrotti, L. Caravatta, M. Di Tommaso, D. Pieragostino, I. Cicalini, C. Rossi, M.C. Cufaro, D. Genovesi

OC-0149

OC-0150

OC-0151

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

92